Yaffe and Aranda's neonatal and pediatric pharmacology therapeutic principles in practice

"Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--

Библиографическая информация
Главный автор: Aranda, Jacob V.
Другие авторы: Van den Anker, John N.
Формат: Электронная книга
Язык:English
Публикация: Philadelphia Wolters Kluwer, [2021]
Редактирование:Fifth edition.
Предметы:
Online-ссылка:EBSCOhost
Перейти в каталог НБ ТГУ
LEADER 05422cam a2200433 i 4500
001 koha001011873
003 OCoLC
005 20250222065903.0
006 m d
007 cr cnu|||unuuu
008 220819s2021 paua ob 001 0 eng d
035 |a koha001011873 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T 
020 |a 9781975112493  |q (electronic bk.) 
020 |a 1975112490  |q (electronic bk.) 
020 |z 9781975112486 
050 4 |a RJ560 
082 0 4 |a 615.1083  |2 23 
049 |a MAIN 
100 1 |a Aranda, Jacob V.,  |9 908338 
245 1 0 |a Yaffe and Aranda's neonatal and pediatric pharmacology  |b therapeutic principles in practice  |c Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. 
250 |a Fifth edition. 
264 1 |a Philadelphia  |b Wolters Kluwer,  |c [2021] 
300 |a 1 online resource  |b illustrations 
500 |a Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed. 
504 |a Includes bibliographical references and index. 
505 0 0 |g Section I:  |t General principles.  |t Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ;  |t Clinical pharmacokinetics in infants and children ;  |t Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ;  |t Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ;  |t Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ;  |t Ethics of drug research in newborns and children ;  |t Precision medicie and therapeutic drug monitoring ;  |t Drug formulations for children --  |g Section II:  |t Pharmacology in special settings and population: the newborn.  |t Role of placenta in drug metabolism and drug transfer ;  |t Maternal medications during pregnancy and lactation ;  |t Principles of neonatal pharmacology ;  |t Renal function and excretion of drugs in the newborn ;  |t Neuroprotective drugs and perinatal brain injury ;  |t Pharmacologic agents for neonatal hyperbilirubinemia ;  |t Pharmacologic treatment of neonatal apnea --  |g Section III:  |t Pharmacology in special settings and population.  |t Therapeutic applications in pediatric intensive care ;  |t Drug therapy in the pediatric emergency department ;  |t Topical medications ;  |t Ophthalmologic drugs in infants and children --  |g Section IV:  |t Antimicrobial pharmacology.  |t Penicillins, cephalosporins, and other [beta]-lactams ;  |t Glycopeptides, lipoglycopeptides, and lipopeptides ;  |t Aminoglycosides ;  |t Macrolides, clindamycin, and oxazolidinones ;  |t Fluoroquinolones ;  |t Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ;  |t Tetracyclines, chloramphenicol, and metronidazole ;  |t Antimalarials ;  |t Anthelminthics drugs in children ;  |t Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ;  |t Antifungal agents ;  |t Antivirals in newborns and children ;  |t Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns --  |g Section V:  |t Neuropharmacology.  |t Anticonvulsants ;  |t Antidepressants and mood stabilizers ;  |t Stimulants, ADHD treatments, and antipsychotics ;  |t Analgesics and sedatives ;  |t Pharmacologic management of neonatal abstinence syndrome ;  |t Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents --  |g Section VI:  |t Immunopharmacology, allergy, and inflammation.  |t Nonsteroida anti-inflammatory drugs ;  |t Antihistamine drugs ;  |t Antiasthmatics ;  |t Immunosuppressive and immunomodulatory drugs --  |g Section VII:  |t Pharmacology of biologic drugs.  |t Microbial therapeutics: beyond probiotics ;  |t Monoclonal antibiotics ;  |t Stem cells ;  |t Drugs, lung development, and pulmonary surfactant ;  |t Childhood vaccines --  |g Section VIII:  |t Cardiorenal drugs.  |t Neonatal cardiovascular pharmacology ;  |t Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ;  |t Antihypertensive drugs ;  |t Diuretics --  |g Section IX:  |t Gastrointestinal pharmacology.  |t Gastrointestinal drugs ;  |t Drugs in inflammatory bowel disease --  |g Section X:  |t Endocrine and hematologic pharmacology.  |t Glucocorticoids ;  |t Insulin and diabetes ;  |t Growth hormone ;  |t Thyroid hormones ;  |t Hematologic agents ;  |t Clinical pharmacology of antineoplastic drugs --  |g Section XI:  |t Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions.  |t Nutrient supplements ;  |t Herbal drugs in children ;  |t Pediatric poisonings and antidotes ;  |t Adverse drug reactions in newborns and children ;  |t Medication errors in children ;  |t Drug interactions in newborns and children --  |g Appendix A1:  |t Neonatal drug formulary --  |g Appendix A2:  |t Pediatric drug formulary. 
520 |a "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--  |c Provided by publisher. 
588 0 |a Vendor-supplied metadata. 
653 0 |a Pediatric pharmacology. 
653 0 |a Children  |x Diseases  |x Chemotherapy. 
655 0 |a EBSCO eBooks  |9 905790 
655 4 |a Electronic books.  |9 899821 
700 1 |a Van den Anker, John N.,  |9 908339 
856 4 0 |3 EBSCOhost  |u https://www.lib.tsu.ru/limit/2023/EBSCO/3241830.pdf 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=1011873 
910 |a EBSCO eBooks 
999 |c 1011873  |d 1011873 
039